TrialWorld journal of gastroenterology2021

Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?

Waled Mohsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.